Literature DB >> 18552861

Itch: a HECT-type E3 ligase regulating immunity, skin and cancer.

G Melino1, E Gallagher, R I Aqeilan, R Knight, A Peschiaroli, M Rossi, F Scialpi, M Malatesta, L Zocchi, G Browne, A Ciechanover, F Bernassola.   

Abstract

The HECT-type E3 ubiquitin ligase (E3) Itch is absent in the non-agouti-lethal 18H or Itchy mice, which develop a severe immunological disease, including lung and stomach inflammation and hyperplasia of lymphoid and hematopoietic cells. The involvement of Itch in multiple signaling pathways and pathological conditions is presently an area of extensive scientific interest. This review aims to bring together a growing body of work exploring Itch-regulated biological processes, and to highlight recent discoveries on the regulatory mechanisms modulating its catalytic activity and substrate recognition capability. Our contribution is also an endeavor to correlate Itch substrate specificity with the pathological defects manifested by the mutant Itchy mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552861     DOI: 10.1038/cdd.2008.60

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  86 in total

1.  It takes two to tango: a new couple in the family of ubiquitin-editing complexes.

Authors:  Ingrid E Wertz
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

2.  HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.

Authors:  Takaya Ishihara; Jun Inoue; Ken-Ichi Kozaki; Issei Imoto; Johji Inazawa
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

3.  Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation.

Authors:  Takashi Yugawa; Koichiro Nishino; Shin-Ichi Ohno; Tomomi Nakahara; Masatoshi Fujita; Naoki Goshima; Akihiro Umezawa; Tohru Kiyono
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

4.  Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

Authors:  B A Patrick; X Gong; A K Jaiswal
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

5.  PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.

Authors:  Fuping You; Hui Sun; Xiang Zhou; Wenxiang Sun; Shimin Liang; Zhonghe Zhai; Zhengfan Jiang
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

6.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Authors:  Y K Satija; S Das
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

7.  Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.

Authors:  Jessica M Perez; Yinghua Chen; Tsan S Xiao; Derek W Abbott
Journal:  J Biol Chem       Date:  2017-12-06       Impact factor: 5.157

8.  Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Authors:  Mohammad Abu-Odeh; Tomer Bar-Mag; Haiming Huang; TaeHyung Kim; Zaidoun Salah; Suhaib K Abdeen; Marius Sudol; Dana Reichmann; Sachdev Sidhu; Philip M Kim; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

9.  Patched-1 proapoptotic activity is downregulated by modification of K1413 by the E3 ubiquitin-protein ligase Itchy homolog.

Authors:  Xiaole L Chen; Pilar Chinchilla; Joanna Fombonne; Lan Ho; Catherine Guix; James H Keen; Patrick Mehlen; Natalia A Riobo
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

10.  Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch.

Authors:  Yoko Ushijima; Chenhong Luo; Maki Kamakura; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  Virol J       Date:  2010-08-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.